A Adanali New member 25 Kas 2022 #1 $3.5 million for a dose? Time to heal this market The eye-popping price of a new haemophilia drug in America should force a big rethink of the pharma business. Patent protection does foster innovation, but this model needs fixing
$3.5 million for a dose? Time to heal this market The eye-popping price of a new haemophilia drug in America should force a big rethink of the pharma business. Patent protection does foster innovation, but this model needs fixing
